AZD-5438

N/A

Report date: 2026/01/07 10:51:38
NME

Base Information

Drug NameAZD-5438
Drug Alias NameAZD-5438
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 2 inhibitorsCyclin-dependent kinase 1 inhibitorsCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 1Cyclin-dependent kinase 2Cyclin-dependent kinase 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTing Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A